Vaccinium myrtillus extract prevents or delays the onset of diabetes--induced blood–retinal barrier breakdown

References

• Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW. 1999. Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 274:23463–23467
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Barber AJ, Khin S, Lieth E, Tarbell JM, Gardner TW. 1998. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47:1953–1959
   PubMed Web of Science ®Google Scholar
• Barber AJ. 2003. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatr 27:283–290
   PubMed Web of Science ®Google Scholar
• Burdulis D, Sarkinas A, Jasutiene I, Stackevicene E, Nikolajevas L, Janulis V. 2009. Comparative study of anthocyanin composition, antimicrobial and antioxidant activity in bilberry (Vaccinium myrtillus L.) and blueberry (Vaccinium corymbosum L.) fruits. Acta Pol Pharm 66:399–408
   PubMed Web of Science ®Google Scholar
• Campa C, Harding SP. 2011. Anti-VEGF compounds in the treatment of neovascular age related macular degeneration. Curr Drug Targets 12:173–181
   PubMed Web of Science ®Google Scholar
• Colantuoni A, Bertuglia S, Magistretti MJ, Donato L. 1991. Effects of Vaccinium Myrtillus anthocyanosides on arterial vasomotion. Arzneimittelforschung 41:905–909
   PubMed Web of Science ®Google Scholar
• Crawford TN, Alfaro DV III, Kerrison JB, Jablon EP. 2009. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 5:8–13
   PubMedGoogle Scholar
• El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI. 2006. Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 168:235–244
   PubMed Web of Science ®Google Scholar
• Ennis SR, Betz AL. 1986. Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate. Invest Ophthalmol Vis Sci 27:1095–1102
   PubMed Web of Science ®Google Scholar
• Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. 1998. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 111:1853–1865
   PubMed Web of Science ®Google Scholar
• Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18:4–25
   PubMed Web of Science ®Google Scholar
• Harhaj NS, Antonetti DA. 2004. Regulation of tight junctions and loss of barrier function in pathophysiology. Int J Biochem Cell Biol 36:1206–1237
   PubMed Web of Science ®Google Scholar
• Kim J, Kim CS, Lee IS, Lee YM, Sohn E, Jo K, Kim JH, Kim JS. 2014. Extract of Litsea japonica ameliorates blood-retinal barrier breakdown in db/db mice. Endocrine 46:462–469
   PubMed Web of Science ®Google Scholar
• Kusari J, Zhou SX, Padillo E, Clarke KG, Gil DW. 2010. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine. Invest Ophthalmol Vis Sci 51:1044–1051
   PubMed Web of Science ®Google Scholar
• Lamy S, Blanchette M, Michaud-Levesque J, Lafleur R, Durocher Y, Moghrabi A, Barrette S, et al. 2006. Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis 27:989–996
   PubMed Web of Science ®Google Scholar
• Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrosio AF, Forrester JV. 2007. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Invest Ophthalmol Vis Sci 48:5257–5265
   PubMed Web of Science ®Google Scholar
• Lietti A, Cristoni A, Picci M. 1976. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneimittelforschung 26:829–832
   PubMed Web of Science ®Google Scholar
• Manimaran A, Sarkar SN, Sankar P. 2010. Toxicodynamics of subacute co-exposure to groundwater contaminant arsenic and analgesic-antipyretic drug acetaminophen in rats. Ecotoxicol Environ Saf 73:94–100
   PubMed Web of Science ®Google Scholar
• Matsunaga N, Chikaraishi Y, Shimazawa M, Yokota S, Hara H. 2010. Vaccinium myrtillus (Bilberry) Extracts Reduce Angiogenesis In Vitro and In Vivo. Evid Based Complement Alternat Med 7:47–56
   PubMed Web of Science ®Google Scholar
• Matsunaga N, Imai S, Inokuchi Y, Shimazawa M, Yokota S, Araki Y, Hara H. 2009. Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo. Mol Nutr Food Res 53:869–877
   PubMed Web of Science ®Google Scholar
• Mehta D, Malik AB. 2006. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86:279–367
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. 1998. The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105:998–1003
   PubMed Web of Science ®Google Scholar
• Murata T, Ishibashi T, Khalil A, Hata Y, Yoshikawa H, Inomata H. 1995. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. Ophthalmic Res 27:48–52
   PubMed Web of Science ®Google Scholar
• Mykkanen OT, Kalesnykas G, Adriaens M, Evelo CT, Torronen R, Kaarniranta K. 2012. Bilberries potentially alleviate stress-related retinal gene expression induced by a high-fat diet in mice. Mol Vis 18:2338–2351
   PubMed Web of Science ®Google Scholar
• Nakajima JI, Tanaka I, Seo S, Yamazaki M, Saito K. 2004. LC/PDA/ESI-MS Profiling and Radical Scavenging Activity of Anthocyanins in Various Berries. J Biomed Biotechnol 2004:241–247
   PubMedGoogle Scholar
• Navaratna D, McGuire PG, Menicucci G, Das A. 2007. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes 56:2380–2387
   PubMed Web of Science ®Google Scholar
• Oak MH, Bedoui JE, Madeira SV, Chalupsky K, Schini-Kerth VB. 2006. Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. Br J Pharmacol 149:283–290
   PubMed Web of Science ®Google Scholar
• Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, et al. 2001. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42:2408–2413
   PubMed Web of Science ®Google Scholar
• Seeram NP. 2008. Berry fruits: compositional elements, biochemical activities, and the impact of their intake on human health, performance, and disease. J Agric Food Chem 56:627–629
   PubMed Web of Science ®Google Scholar
• Sekher Pannala A, Chan TS, O'Brien PJ, Rice-Evans CA. 2001. Flavonoid B-ring chemistry and antioxidant activity: fast reaction kinetics. Biochem Biophys Res Commun 282:1161–1168
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itin A, Soffer D, Keshet E. 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845
   PubMed Web of Science ®Google Scholar
• Takikawa M, Inoue S, Horio F, Tsuda T. 2010. Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 140:527–533
   PubMed Web of Science ®Google Scholar
• Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, et al. 1997. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12:99–109
   PubMed Web of Science ®Google Scholar
• Wang F, Flanagan J, Su N, Wang LC, Bui S, Nielson A, Wu X, Vo HT, Ma XJ, Luo Y. 2012. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J Mol Diagn 14:22–29
   PubMed Web of Science ®Google Scholar
• Wang LS, Stoner GD. 2008. Anthocyanins and their role in cancer prevention. Cancer Lett 269:281–290
   PubMed Web of Science ®Google Scholar
• Watson PM, Anderson JM, Vanltallie CM, Doctrow SR. 1991. The tight-junction-specific protein ZO-1 is a component of the human and rat blood-brain barriers. Neurosci Lett 129:6–10
   PubMed Web of Science ®Google Scholar
• Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. 2006. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54:4069–4075
   PubMed Web of Science ®Google Scholar
• Xu Q, Qaum T, Adamis AP. 2001. Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 42:789–794
   PubMed Web of Science ®Google Scholar
• Yamagata M, Rook SL, Sassa Y, Ma RC, Geraldes P, Goddard L, Clermont A, et al. 2006. Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects. FASEB J 20:2058–2067
   PubMed Web of Science ®Google Scholar
• Zhang SX, Ma JX, Sima J, Chen Y, Hu MS, Ottlecz A, Lambrou GN. 2005. Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am J Pathol 166:313–321
   PubMed Web of Science ®Google Scholar
• Zhu Y, Ling W, Guo H, Song F, Ye Q, Zou T, Li D, et al. 2013. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: a randomized controlled trial. Nutr Metab Cardiovasc Dis 23:843–849
   PubMed Web of Science ®Google Scholar